Chromium attenuates hepatic damage in a rat model of chronic cholestasis

Life Sciences

Volumn 84, Issue 17-18, 2009, Pages 606-614

  Chen, Wen Ying ^a   Chen, Chun Jung ^b   Liao, Jiunn Wang ^a   Mao, Frank Chiahung ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cholestasis; Chromium; Hepatotoxicity; Oxidative stress

Indexed keywords

CHROMIUM CHLORIDE; ACTIN; ANTIOXIDANT; CHLORIDE; CHROMIUM DERIVATIVE; MADH2 PROTEIN, RAT; MADH3 PROTEIN, RAT; SMAD2 PROTEIN; SMAD3 PROTEIN; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTASIS; CHRONIC DISEASE; CONTROLLED STUDY; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; ZYMOGRAPHY; ANIMAL; DIET SUPPLEMENTATION; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; CHOLESTASIS; CHROMIUM; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; ACTINS; ANTIOXIDANTS; CHLORIDES; CHROMIUM COMPOUNDS; DIETARY SUPPLEMENTS; LIVER CIRRHOSIS; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 63649136959     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.02.003     Document Type: Article

References (50)

1. Abraham A.S., Brooks B.A., and Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41 7 (1992) 768-771
2. Akiko Y., Osamu W., and Hiramitsu S. Purification and properties of biologically active chromium complex from bovine colostrum. The Journal of Nutrition 118 1 (1998) 39-45
3. Alpini G., Glasser S., Alvaro D., Ueno Y., Marzioni M., Francis H., Baiocchi L., Stati T., Barbaro B., Phinizy J.L., Mauldin J., and Lesage G. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol-3-kinase-dependent pathway in rats. Gastroenterology 123 4 (2002) 1226-1237
4. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Elevated intake of supplemental chromium improves glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 11 (1997) 1786-1791
5. Atac I.A., Peksel A., Yanardag R., Sokmen B.B., Doger M.M., and Bilen Z.G. The effect of combined treatment with niacin and chromium (III) chloride on the different tissues of hyperlipemic rats. Drug and Chemical Toxicology 29 4 (2006) 363-377
6. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., and Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180 1 (2002) 5-22
7. Baron V., and Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochimica et Biophysica Acta 1472 1-2 (1999) 173-180
8. Baroni G.S., D'Ambrosio L., Ferretti G., Casini A., Sario A.D., Salzano R., Ridolfi F., Saccomanno S., Jezequel A.M., and Benedetti A. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 27 3 (1998) 720-726
9. Bataller R., and Brenner D.A. Liver fibrosis. Journal of Clinical Investigation 115 2 (2005) 209-218
10. Bauer M., and Schuppan D. TGF-β1 in liver fibrosis: time to change paradigms. FEBS Letters 502 1-2 (2001) 1-3
11. Beaussier M., Wendum D., Schiffer E., Dumont S., Rev C., Lienhart A., and Housset C. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Laboratory Investigation 87 (2007) 292-303
12. Beck P.L., and Lee S.S. Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis. Journal of Hepatology 23 2 (1995) 235
13. Chen W.Y., Chen C.J., Liu C.H., and Mao F.C. Chromium supplementation enhances insulin signaling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes, Obesity & Metabolism (2008) 10.1111/j.1463-1326.2008.00936.x
14. Cheng H.H., Lai M.H., Hou W.C., and Huang C.L. Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. Journal of Agricultural and Food Chemistry 52 5 (2004) 1385-1389
15. Desmet V., Roskams T., and Van Eyken P. Ductular reaction in the liver. Pathology, Research & Practice 191 6 (1995) 513-524
16. Donaldson R.M., and Barreras R.F. Intestinal absorption of trace quantities of chromium. Journal of Laboratory and Clinical Medicine 68 3 (1966) 484-493
17. Grant A.P., and McMullen J.K. The effect of brewer's yeast containing glucose tolerance factor on the response to treatment in type 2 diabetes: A short controlled study. The Ulster Medical Journal 51 2 (1982) 110-114
18. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-beta in hepatic fibrosis. Frontiers in Bioscience 7 (2002) d793-d807
19. Guicciardi M.E., and Gores G.J. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Digestive and Liver Disease 34 6 (2002) 387-392
20. Jain S.K., Rains J.L., and Croad J.L. High glucose and ketosis (acetoacetate) increase, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxidants & Redox Signaling 9 10 (2007) 1581-1590
21. Jain S.K., Rains J.L., and Croad J.L. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radical Biology & Medicine 43 8 (2007) 1124-1131
22. Jamall I.S., Finelli V.N., and Que Hee S.S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Analytical Biochemistry 112 1 (1981) 70-75
23. Kawamura K., Kobayashi Y., Kageyama F., Kawasaki T., Nagasawa M., Toyokuni S., Uchida K., and Nakamura H. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis. American Journal of Gastroenterology 95 12 (2000) 3596-3601
24. Kimura H., Sawada T., Oshima S., Kozawa K., Ishioka T., and Kato M. Toxicity and roles of reactive oxygen species. Current Drug Targets - Inflammation & Allergy 4 4 (2005) 489-495
25. Kossakowska A.E., Edwards D.R., Lee S.S., Urbanski L.S., Stabbler A.L., Zhang C.L., Phillips B.W., Zhang Y., and Urbanski S.J. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. American Journal of Pathology 153 6 (1998) 1895-1902
26. Lane J.R., Starbuck E.M., Johnson A.K., and Fitts D.A. Effects of bile duct ligation and captopril on salt appetite and rennin-aldosterone axis in rats-A proposal for the initiation of renal sodium and water retention in cirrhosis. Physiology & Behavior 66 3 (1999) 419-425
27. Macmillan-Crow L.A., and Cruthirds D.L. Manganese superoxide dismutase in disease. Free Radical Research 34 4 (2001) 325-336
28. Mahdi G.S. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidemia and atherosclerosis. Diabetic Medicine 13 (1996) 389-391
29. Mastruzzo C., Crim N., and Vancheri C. Role of oxidative stress in pulmonary fibrosis. Monaldi Archives for Chest Disease 57 3-4 (2002) 173-176
30. Mertz W., Roginsky E.E., and Reba R.C. Biological activity and fate of intravenous chromium III in the rat. American Journal of Physiology 209 3 (1965) 489-494
31. Mita Y., Ishihara K., Fukuchi Y., Fukuya Y., and Yasumoto K. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biological Trace Element Research 105 (2005) 229-248
32. Nagase H., and Woessner J.F. Matrix metalloproteinases. Journal of Biological Chemistry 274 31 (1999) 21491-21494
33. Oberley L.W. Free radicals and diabetes. Free Radical Biology & Medicine 5 2 (1988) 13-24
34. Olaso E., and Friedmann S.L. Molecular regulation of hepatic fibrogenesis. Journal of Hepatology 29 5 (1998) 836-847
35. Parola M., Leonarduzzi G., Robino G., Albano E., Poli G., and Dianzani M.U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radical Biology & Medicine 20 3 (1996) 351-359
36. Pastor A., Collado P.S., Almar M., and Gonzalez-Gallego J. Antioxidant enzyme status in biliary-obstructed rats: effects of N-acetylcysteine. Journal of Hepatology 27 2 (1997) 363-370
37. Pei D., Hsieh C.H., Hung Y.J., Li J.C., Lee C.H., and Kuo S.W. The influence of chromium chloride-containing milk on glycemic control of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Metabolism 55 7 (2006) 923-927
38. Poli G., and Parola M. Oxidative damage and fibrogenesis. Free Radical Biology & Medicine 22 1-2 (1997) 287-305
39. Preuss H.G., Tarrell S.T., Scheckenbach R., Lieberman S., and Anderson R.A. Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. Journal of the American College Nutrition 17 2 (1998) 116-123
40. Rutenberg A.M., Kim H., Fischbein J.W., Hanker J.S., Wasserkrug H.L., and Seligman A.M. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. Journal of Histochemistry and Cytochemistry 17 8 (1969) 517-526
41. Seifert W.F., Bosma A., Hendriks H.F., van Leeuwen R.E., van Thiel de Ruiter G.C., Seifert Bock I., Knook D.L., and Brouwer A. Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats. Liver 15 1 (1995) 1-8
42. Shackelford C., Long G., Wolf J., Okerberg C., and Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicologic Pathology 30 1 (2002) 93-96
43. Shek F.W., and Benyon R.C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis?. European Journal of Gastroenterology & Hepatology 16 2 (2004) 123-126
44. Sokol R.J., Devereaux M., and Khandwala R.A. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. Journal of Lipid Research 32 (1991) 1349-1357
45. Sokol R.J., Devereaux M.W., and Khandwala R. Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat. Pediatric Research 44 3 (1998) 397-401
46. Tan G.Y., Bi J.M., Zhang M.H., Feng J.H., Xie P., and Zhang S.S. Effects of chromium picolinate on oxidative damage in primary piglet hepatocytes. Biological Trace Element Research 126 Suppl 1 (2008) S69-79
47. Tezuka M., Ishii S., and Okada S. Chromium (III) decreases carbon tetrachloride-originated trichloromethyl radical in mice. Journal of Inorganic Biochemistry 44 4 (1991) 261-265
48. Tezuka M., Momiyama K., Edano T., and Okada S. Protective effect of chromium (III) on acute lethal toxicity of carbon tetrachloride in rats and mice. Journal of Inorganic Biochemistry 42 1 (1991) 1-8
49. Xia X., Francis H., Glaser S., Alpini G., and LeSage G. Bile acid interactions with cholangiocytes. World Journal of Gastroenterology 12 22 (2006) 3553-3563
50. Yang J., and Liu Y. Dissection of key events in tubular epithelial-to-myofibroblast transition and its implications in renal interstitial fibrosis. American Journal of Pathology 159 4 (2001) 1465-1475